Terminated NA INTERVENTIONAL 2-arm NCT01501643

Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease (VPACS)

Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Sickle Cell-hemoglobin SS Disease Vaso-occlusive Crisis

Interventions Non invasive positive pressure ventilation Spirometry

Updated 6 times since 2017 Last updated: Feb 11, 2026 Started: Nov 30, 2011 Primary completion: Nov 30, 2014 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

decision of the promoter

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

Listed as NCT01501643, this NA trial focuses on Sickle Cell-hemoglobin SS Disease and Vaso-occlusive Crisis and remains terminated or withdrawn. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Terminated NA
Sep 2024 — Feb 2026 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France